Preformed Line Products heads into Thursday's Q2 earnings report having shed a quarter of its value in a month — and with a cluster of insider sales at levels the stock no longer trades near.
The insider angle is the sharpest part of this story. In early June, six executives — including the CFO, President, and an Executive VP — sold a combined $2.8 million net worth of shares at prices between $358 and $363. That is roughly 20% above where the stock closed Tuesday at $297.11. The Executive Chairman had done the same in March, selling 2,500 shares near $260. The pattern is clear: insiders were consistent sellers into strength, and the stock has since given back those gains and more. None of the recent 90-day activity shows any buying to offset those disposals.
The borrow market offers little drama by comparison, and that itself is worth noting. Short interest has climbed about 12% over the past week to roughly 5% of the free float — a meaningful move, but the lending conditions remain relaxed. Borrow availability runs near 579%, meaning there are nearly six shares available to lend for every one already borrowed. Cost to borrow is just 0.44%, close to its lowest level in the past month. Shorts are adding, but they are doing so cheaply and without any squeeze risk. The ORTEX short score has ticked up to 50.4 — mildly elevated but well below territory that would suggest aggressive positioning. The overall picture is one of measured, low-friction short accumulation, not a crowded trade.
The only analyst on record is Freedom Broker, which upgraded PLPC to Buy with a $275 target back in March — data that is now over four months old and carries limited weight given the stock has since traded both above and well below that level. At $297, the stock is actually trading above that stale target, making it of limited practical use. Ownership concentration is a notable structural feature: the Ruhlman family (Randall and Robert) collectively account for over 46% of shares, effectively limiting float. Wasatch Advisors disclosed a substantial new position at June quarter-end, adding 264,478 shares to reach 7.7% of shares outstanding — the most significant institutional move in the recent filing cycle.
Earnings history adds useful context for Thursday's print. The last four quarterly reports all produced negative one-day reactions, ranging from -0.9% to -6.8%. The April 2026 release saw the stock fall 6.8% on the day before recovering modestly over the following week. A fifth consecutive negative day-one reaction would extend that pattern, though the stock's 25% drawdown into this print means the setup is different from prior quarters — the market has already done significant re-pricing.
What to watch Thursday evening: whether revenue growth and margin commentary justify the rebound Wasatch and others appear to be positioning for, and whether the pace of short-interest accumulation accelerates or reverses in the sessions that follow.
See the live data behind this article on ORTEX.
Open PLPC on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
